 ALAMEDA, Calif.--BUSINESS WIRE--AgeX Therapeutics, Inc. AgeX; NYSE American: AGE, a biotechnology company developing therapeutics for human aging and regeneration, announced today the online publication of data relating to regeneration, aging, and cancer in bioRxiv. The paper titled Differential Expression of α, β, and γ Protocadherin Isoforms During Differentiation, Aging, and Cancer presents for the first time data relating to mechanisms cells may use in the process of regeneration. T 